Monday, January 4, 2016

Sexually Transmitted Diseases: From HPV to HTLV - Clinical Profile and Associated Factors

The Brazilian Ministry of Health recommends the performance of serological tests in patients with clinical signs of Sexually Transmitted Diseases. However, data are lacking to affirm the necessity of testing these patients for human T-lymphotropic virus type 1 or type 2. This is a cross-sectional study with 120 patients seen at the Sexually Transmitted Diseases unit of the Sanitary Dermatology Outpatient Clinic of Rio Grande do Sul. The serum from none of the patients was positive for human T-lymphotropic virus type 1 or type 2. Viral warts were the most frequent diagnosis. Drug use was confirmed as a risk factor and high educational levels were found to be a protective factor against Sexually Transmitted Diseases.

Below:  Frequency distribution of the variables according to the syndromic approach to STD diagnosis
Genital ulcerDischarges*Genital wartsPelvic PainTotalp
History of HIVYes6350140.253§
No2130533107
Drugs useYes1525483910.039§
No12810030
Condoms useAlways1010190390.282§
Sometimes121832163
Never557219
Steady partnerYes1818361730.593§
No91522248
Multiple partnersYes813161380.702§
No192042283
Partner with STDYes59100240.433§
No121133258
Does not know101315139
*the sum of the urethral and vaginal discharges.
§Pearson's chi-square test

Full article at:   http://goo.gl/ZJc1JO

1Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) – Porto Alegre (RS), Brazil.
2Hospital Nossa Senhora da Conceição – Porto Alegre (RS), Brazil.
3Ambulatório de Dermatologia Sanitária da Secretaria de Saúde do Estado do Rio Grande do Sul – Porto Alegre (RS), Brazil.
MAILING ADDRESS: Fabíola Suris da Silveira, Av Joao Pessoa, 1327 Farroupilha, 90040001 - Porto Alegre - RS, Brazil. E-mail:moc.liamtoh@sirusibaf



No comments:

Post a Comment